What is PMI's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.02B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for PMI?

P/E (TTM) is n/a and 52-week range is $2.65 to $684.00 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s PMI figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for PMI?

The company profile lists revenue (TTM) near $349M, net income (TTM) near $-154.91B, EPS (TTM) near $-11.22 when available from the market-data feed. Figures are informational and may lag live markets.

Where is Picard Medical Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Tucson, Arizona, US, 102.7M shares outstanding, ISIN US71953R1086 when available from company profile and filing metadata.

Picard Medical Inc

$PMI

Health Care · Health Care Equipment & Supplies

Run Scenarios

$9.48

-2.07%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

Picard Medical, Inc. is a medical technology company, which manufactures and sells the only U.S. FDA, and Health Canada approved implantable SynCardia TAH. The company is headquartered in Tucson, Arizona and currently employs 75 full-time employees. The company went IPO on 2025-08-29. SynCardia is a medical technology company that manufactures and sells the only United States Food and Drug Administration (FDA) and Health Canada-approved implantable total artificial heart (SynCardia TAH). The SynCardia TAH is a biventricular replacement device that consists of the SynCardia TAH implant, an external pneumatic driver that delivers precisely calibrated pulses of air to drive the implant, and drivelines that connect the driver to the implant. The SynCardia TAH implant is a system that consists of two independent artificial ventricles which are powered by an external pneumatic driver. Each artificial ventricle is made of a semi-rigid polyurethane housing and a rigid polyurethane base, with a four-layer flexible polyurethane diaphragm separating the blood chamber from the air chamber.

Employees

Website

picardmedical.com

IPO

2025-08-29

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)

Net income (TTM)